Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1990 4
1991 2
1992 3
1993 4
1994 4
1995 5
1996 2
1997 3
1998 2
1999 3
2001 2
2002 3
2003 3
2005 3
2006 4
2007 10
2008 7
2009 4
2010 5
2011 3
2012 8
2013 2
2014 4
2015 8
2017 2
2018 1
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L, Poggio F, Blondeaux E, De Placido S, Giuliano M, Forestieri V, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Vaccaro A, Cognetti F, Fabi A, Gasparro S, Garrone O, Alicicco MG, Urracci Y, Mansutti M, Poletti P, Correale P, Bighin C, Puglisi F, Montemurro F, Colantuoni G, Lambertini M, Boni L; Gruppo Italiano Mammella Investigators. Del Mastro L, et al. Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10. Lancet Oncol. 2022. PMID: 36370716 Clinical Trial.
Communication models for doctor-patient relationships.
Aitini E, Martignoni G, Labianca R; Italian Group for the study of Digestive Tract Cancer (GISCAD). Aitini E, et al. J Cancer Educ. 2014 Jun;29(2):211-2. doi: 10.1007/s13187-014-0616-z. J Cancer Educ. 2014. PMID: 24497381 No abstract available.
When the oncologist becomes the patient.
Aitini E. Aitini E. Curr Oncol. 2019 Jun;26(3):166. doi: 10.3747/co.26.4619. Epub 2019 Jun 1. Curr Oncol. 2019. PMID: 31285660 Free PMC article. No abstract available.
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis.
Bringhen S, Offidani M, Palmieri S, Pisani F, Rizzi R, Spada S, Evangelista A, Di Renzo N, Musto P, Marcatti M, Vallone R, Storti S, Bernardini A, Centurioni R, Aitini E, Palmas A, Annibali O, Angelucci E, Ferrando P, Baraldi A, Rocco S, Andriani A, Siniscalchi A, De Stefano V, Meneghini V, Palumbo A, Grammatico S, Boccadoro M, Larocca A. Bringhen S, et al. Among authors: aitini e. Crit Rev Oncol Hematol. 2018 Oct;130:27-35. doi: 10.1016/j.critrevonc.2018.07.003. Epub 2018 Jul 18. Crit Rev Oncol Hematol. 2018. PMID: 30196909 Free article. Review.
FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies.
Petrelli F, Coinu A, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Aitini E, Barni S; Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente (GISCAD). Petrelli F, et al. Among authors: aitini e. Pancreas. 2015 May;44(4):515-21. doi: 10.1097/MPA.0000000000000314. Pancreas. 2015. PMID: 25872127 Review.
End of life in cancer patients: drugs or words?
Aitini E, Adami F, Cetto GL. Aitini E, et al. Ann Oncol. 2010 May;21(5):914-5. doi: 10.1093/annonc/mdq218. Ann Oncol. 2010. PMID: 20423917 Free article. No abstract available.
The chronic condition of life.
Aitini E. Aitini E. Curr Oncol. 2015 Aug;22(4):e323-4. doi: 10.3747/co.22.2282. Curr Oncol. 2015. PMID: 26300684 Free PMC article. No abstract available.
A good death for cancer patients: still a dream?
Aitini E, Cetto GL. Aitini E, et al. Ann Oncol. 2006 May;17(5):733-4. doi: 10.1093/annonc/mdl061. Epub 2006 Mar 24. Ann Oncol. 2006. PMID: 16565211 Free article. No abstract available.
97 results